Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
180 hedge funds and large institutions have $691M invested in Immunogen Inc in 2017 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 18 closing their positions.
128% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 18
28% more capital invested
Capital invested by funds: $542M → $691M (+$149M)
15% more funds holding
Funds holding: 157 → 180 (+23)
11% more call options, than puts
Call options by funds: $5.99M | Put options by funds: $5.38M
26% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$18.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$18.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.5M |
| 5 |
O
OrbiMed
New York
|
+$10M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$9.48M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.21M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.59M |
| 4 |
Goldman Sachs
New York
|
-$2.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$2.17M |
IMGN Hedge Fund Activity: Q3 2017 in Review
180 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2017, worth a combined $691M — up 28% from $542M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new IMGN positions and 18 closed out — a net gain of 23 holders — while 43 added to existing stakes and 58 trimmed.
The largest buyer was Vanguard Group, adding an estimated $20.1M. The largest seller was ClearBridge Investments, cutting an estimated $9.48M.
- 180 institutional investors held Immunogen Inc (IMGN) as of Q3 2017, up from 157 in Q2 2017.
- Funds reported $691M of Immunogen Inc stock for Q3 2017, up 28% quarter-over-quarter.
- 41 funds opened new Immunogen Inc positions in Q3 2017 and 18 closed out, a net change of +23 holders.
- The largest Immunogen Inc buyer in Q3 2017 was Vanguard Group, an estimated $20.1M added.
- The largest Immunogen Inc seller in Q3 2017 was ClearBridge Investments, an estimated $9.48M sold.
Based on aggregated 13F filings for Q3 2017.